| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Peter A. Thompson | Director | 2026-05-27 | 101 | $44.49 | $4.49kSell |
| Orbimed Advisors LLC | Director | 2026-05-27 | 101 | $44.49 | $4.49kSell |
| Orbimed Advisors LLC | Director | 2026-05-11 | 184,639 | $46.22 | $8.53MSell |
| Peter A. Thompson | Director | 2026-05-11 | 184,639 | $46.22 | $8.53MSell |
| Peter A. Thompson | Director | 2026-05-08 | 59,767 | $44.58 | $2.66MSell |
| Orbimed Advisors LLC | Director | 2026-05-08 | 59,767 | $44.58 | $2.66MSell |
| Peter A. Thompson | Director | 2026-05-07 | 48,546 | $44.61 | $2.17MSell |
| Orbimed Advisors LLC | Director | 2026-05-07 | 48,546 | $44.61 | $2.17MSell |
| Peter A. Thompson | Director | 2026-04-18 | 2,948 | $44.52 | $131.24kSell |
| Orbimed Advisors LLC | Director | 2026-04-18 | 2,948 | $44.52 | $131.24kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 21.94% | 9,905,045 | $363.81M | Institution |
| Tpg GP A LLC | 14.39% | 6,494,962 | $238.56M | Institution |
| Tpg GP A LLC | 14.39% | 6,494,962 | $238.56M | Insider |
| Peter A. Thompson | 14.12% | 6,376,680 | $234.22M | Insider |
| Atlas Venture Fund XI LP | 8.18% | 3,694,020 | $135.68M | Insider |
| Orbimed Advisors LLC | 7.82% | 3,530,702 | $129.68M | Institution |
| Viking Global Investors LP | 7.08% | 3,195,181 | $117.36M | Institution |
| Bruce Booth | 6.63% | 2,995,602 | $110.03M | Insider |
| Atlas Venture Life Science Advisors LLC | 6.63% | 2,995,602 | $110.03M | Institution |
| Orbimed Advisors LLC | 5.92% | 2,671,721 | $98.13M | Insider |